Focal Segmental Glomerulosclerosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TVTX | D | Travere Therapeutics, Inc. | -2.11 | |
ZVSA | F | ZyVersa Therapeutics, Inc. | -4.36 |
Related Industries: Biotechnology Drug Manufacturers - Major
Related ETFs - A few ETFs which own one or more of the above listed Focal Segmental Glomerulosclerosis stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | C | BioShares Biotechnology Products Fund | 1.57 | |
XBI | C | SPDR S&P Biotech ETF | 0.51 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 0.36 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 0.33 | |
LABU | C | Direxion Daily S&P Biotech Bull 3X Shares | 0.29 |
Compare ETFs
- Focal Segmental Glomerulosclerosis
Focal segmental glomerulosclerosis (FSGS) is a histopathologic finding of scarring (sclerosis) of glomeruli and damage to renal podocytes. This process damages the filtration function of the kidney, resulting in protein loss in the urine. FSGS is a leading cause of excess protein loss—nephrotic syndrome—in children and adults. Signs and symptoms include proteinuria, water retention, and edema. Kidney failure is a common long-term complication of disease. FSGS can be classified as primary versus secondary depending on whether a particular toxic or pathologic stressor can be identified as the cause. Diagnosis is established by renal biopsy, and treatment consists of glucocorticoids and other immune-modulatory drugs. Response to therapy is variable, with a significant portion of patients progressing to end-stage kidney failure. FSGS is estimated to occur in 2-3 persons per million, with males and African peoples at higher risk .
Popular Now
Recent Comments
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
From the Blog
Featured Articles